Losartan 100mg pharmacology
Pro Research Analysisby 
Searched over 200M research papers
Losartan 100mg Pharmacology: Mechanism of Action and Clinical Use
Losartan 100mg is an angiotensin II receptor blocker (ARB) that works by selectively blocking the AT1 receptor, preventing angiotensin II from exerting its vasoconstrictive and aldosterone-secreting effects. This leads to blood vessel relaxation, reduced blood pressure, and decreased workload on the heart. Losartan is primarily used to manage hypertension, heart failure, and protect kidney function in patients with diabetic nephropathy and other renal diseases Burnier2011Goa1996Tolou_Ghamari2023.
Pharmacokinetics of Losartan 100mg
After oral administration, losartan is rapidly absorbed, reaching peak plasma concentrations within 1–2 hours. Its bioavailability is about 25–35%, and it is highly protein-bound (about 78%). Losartan is metabolized in the liver to an active metabolite, E3174, which significantly contributes to its antihypertensive effect and provides a sustained action over 24 hours, supporting once-daily dosing Goa1996Tolou_Ghamari2023. The drug is not removed by hemodialysis .
Efficacy and Dose Considerations
Clinical studies show that losartan 100mg daily provides effective blood pressure reduction, with some evidence suggesting that 50mg may be insufficient for optimal control in many patients. Increasing the dose to 100mg can offer additional benefits, especially in those who do not achieve target blood pressure with 50mg Burnier2011Ikeda1997Weber1995. The antihypertensive effect of 100mg is comparable to other standard treatments like enalapril and atenolol Goa1996Weber1992Weber1995.
Safety and Tolerability
Losartan 100mg is generally well tolerated. The most common side effect is mild dizziness, with a low risk of first-dose hypotension. The incidence of cough is similar to placebo, making it a good alternative for patients who develop cough with ACE inhibitors. Clinically significant metabolic or laboratory abnormalities are rare, and renal function is preserved even in patients with renal insufficiency Goa1996Weber1992Weber1995. Adverse events are usually mild and resolve without complications .
Pharmacokinetics in Special Populations
In patients with renal insufficiency, the pharmacokinetics of losartan and its active metabolite are only minimally affected. Although renal clearance decreases with worsening kidney function, this does not lead to significant accumulation or require dose adjustment, as most of the drug is eliminated by non-renal pathways Ska1995Goa1996.
Drug Interactions and Combination Therapy
Losartan can be safely combined with low-dose diuretics like hydrochlorothiazide for enhanced blood pressure control. It has notable interactions with other antihypertensive agents and some drugs metabolized by cytochrome P450 enzymes, so monitoring is advised when used with drugs like phenobarbital, rifampin, or fluconazole Tolou_Ghamari2023Weber1995. Fixed-dose combinations with other agents, such as amlodipine and rosuvastatin, have shown pharmacokinetic equivalence and may improve medication adherence .
Additional Therapeutic Benefits
Beyond blood pressure control, losartan may help prevent or treat muscle toxicity associated with statin use and could have beneficial effects on gut microbiota related to hypertension 김성욱2011Tolou_Ghamari2023. It is also effective in high-risk groups, such as renal transplant recipients with hypertension .
Conclusion
Losartan 100mg is a well-established, effective, and well-tolerated ARB for the management of hypertension and related cardiovascular and renal conditions. Its pharmacokinetic profile supports once-daily dosing, and it remains effective and safe even in patients with renal impairment. The 100mg dose is often preferred for optimal blood pressure control, and losartan’s favorable safety profile makes it a valuable option in clinical practice Burnier2011Sambandan2025Ska1995+6 MORE.
Sources and full results
Most relevant research papers on this topic